tenk.fyi

Spyre Therapeutics, Inc.

SYRENasdaq· Pharmaceutical Preparations

Price History

Revenue

$0

Net Income

-$155.2M

25.4% YoY

EPS

-

Cash

$85.7M

4.1% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade